Connor, Clark & Lunn Investment Management (CC&L)
TDOC icon

Connor, Clark & Lunn Investment Management (CC&L)’s Teladoc Health TDOC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,510,823
Closed -$13.2M – 1717
2025
Q2 		$13.2M Sell
1,510,823
-47,546
-3% -$345K 0.05% 334
2025
Q1 		$12.4M Buy
1,558,369
+200,494
+15% +$2.03M 0.05% 279
2024
Q4 		$12.3M Sell
1,357,875
-343,286
-20% -$3.31M 0.06% 271
2024
Q3 		$15.6M Buy
1,701,161
+228,004
+15% +$1.89M 0.08% 197
2024
Q2 		$14.4M Buy
1,473,157
+154,982
+12% +$1.89M 0.06% 231
2024
Q1 		$19.9M Buy
1,318,175
+681,496
+107% +$12.4M 0.09% 205
2023
Q4 		$13.7M Sell
636,679
-21,756
-3% -$401K 0.06% 237
2023
Q3 		$12.2M Buy
658,435
+57,989
+10% +$1.35M 0.06% 232
2023
Q2 		$15.2M Sell
600,446
-74,290
-11% -$1.87M 0.08% 195
2023
Q1 		$17.5M Sell
674,736
-703
-0.1% -$18.8K 0.09% 175
2022
Q4 		$16M Sell
675,439
-17,930
-3% -$483K 0.09% 169
2022
Q3 		$17.6M Buy
693,369
+341,471
+97% +$12M 0.12% 137
2022
Q2 		$11.7M Buy
351,898
+316,492
+894% +$13.4M 0.07% 186
2022
Q1 		$2.55M Buy
+35,406
New +$2.55M 0.01% 448

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s TDOC Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 1,510,823 shares — an estimated $13.2M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TDOC in Q1 2022 and held it in 14 quarters. The position peaked at $19.9M in Q1 2024. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,510,823 Teladoc Health shares in Q3 2025, an estimated $13.2M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Teladoc Health in Q1 2022 and held it in 14 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Teladoc Health position peaked at $19.9M in Q1 2024.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.